Comment
Author: Admin | 2025-04-28
According to statistics, more than 60% of Chinese men aged 35 and above suffer from sexual dysfunction. Sildenafil is developed by Pfizer to treat penile erectile dysfunction, pulmonary hypertension, mountain sickness, etc. Pfizer's application for Viagra's patent was approved by China's State Intellectual Property Office in 1994. According to the patent law of China, the patent should be valid for 20 years till 2014. After the expiration of the patent, pharmaceutical companies can produce Sildenafil as long as they have obtained the approval. Therefore, Chinese manufacturers began to launch Sildenafil in 2014. CRI's market investigation shows that China's Sildenafil market is dominated by Pfizer's Viagra, Baiyunshan's Jinge and Yabang Aipusen's Wanfeile. The market share of Pfizer's Viagra, either by sales volume or by sales value, exceeded 90% in 2017. However, it will decrease as China-made counterparts are launched. The number of erectile dysfunction patients will continue to rise in the next few years as the economy develops, the lifestyle changes, and psychological pressures increase in China. Furthermore, Sildenafil is becoming more affordable with the rise of income in China. The sales value of Sildenafil exceeded CNY 30 million in 2017, and the market will continue to grow in the next few years. Topics Covered:Development environment of China's Sildenafil marketSales of Sildenafil in ChinaCompetition pattern of China's Sildenafil marketPrices of Sildenafil in China's HospitalsDriving forces and market opportunities for China's Sildenafil marketProspect of China's Sildenafil market Table of Contents 1 Relevant Concepts of Sildenafil1.1 Indications for Sildenafil1.2 Development History of Sildenafil in China1.3 Patents and Government Approval on Sildenafil in China2 Sales of Sildenafil in China, 2013-20172.1 Sales Value2.1.1 Overall Sales Value2.1.2 Sales Value by Region2.2 Sales Volume2.2.1 Overall Sales Volume2.2.2 Sales Volume by Region2.3 Sales of Sildenafil by Dosage Form in China, 2013-20173 Analysis onMajor Sildenafil Manufacturers in China, 2013-20173.1 Analysis on Market Share of Major Sildenafil Manufacturers3.1.1 Market Share by Sales Value3.1.2 Market Share by Sales Volume3.2 Pfizer3.2.1 Enterprise Profile3.2.2 Sales of Pfizer's Sildenafil in China3.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory ("Baiyunshan")3.4 Jiangsu Yabang Aipusen Pharmaceutical Co., Ltd. ("Yabang Aipusen")4 Prices of Sildenafil in China, 2017-20184.1 Pfizer (Viagra)4.2 Baiyunshan (Jinge)4.3 Yabang Aipusen (Wanfeile)5 Prospect of China's Sildenafil Market, 2018-20225.1 Forecast on Market Size5.2 Forecast on Market TrendSelected ChartsChart Sales of Sildenafil in China, 2013-2017Chart Sales Value of Sildenafil in Parts of China, 2013-2017Chart Sales Volume of Sildenafil in China, 2013-2017Chart Sales Volume of Sildenafil
Add Comment